Tempest Therapeutics Inc（TPST）價格預測TPSTTempest Therapeutics Inc

Alphio's TPST stock price prediction model matches the current Tempest Therapeutics Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $1.08 (+2.41%). The 1-week path is $1.02 (-2.51%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

Tempest Therapeutics Inc is not a good buy right now due to its ongoing financial losses and cash flow issues. The current price is $1.06, with a year-to-date change of -64.07%, indicating significant underperformance. Although the recent quarterly loss improved to -$5.2 million, the company ended Q2 with only $1.7 million in cash, raising concerns about liquidity. The RSI is at 47.458, suggesting a neutral momentum, and the forward P/E ratio is currently not applicable due to negative earnings. The main risk is the company's declining cash reserves, which could hinder operational capabilities.

Tempest Therapeutics Inc (TPST) last closed at $1.05, losing -4.55%. These facts feed the 1-day and 1-week TPST price prediction above.